Research, Gym Tour, Wellness Tour, Wellness Tourism, Fitness Industry Advocacy, Exercise Science, Fitness Technology Hannah Ungar Research, Gym Tour, Wellness Tour, Wellness Tourism, Fitness Industry Advocacy, Exercise Science, Fitness Technology Hannah Ungar

Roche Announces Positive Results for New Oral GLP-1 Obesity Drug

Roche announces positive Phase I trial results for CT-996, a new oral GLP-1 receptor agonist for type 2 diabetes and obesity. The study shows significant weight loss and good tolerability, paving the way for further development.

Read More